One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
Top stories from 2023 in cell and gene therapy
This year, ACGT led in advancing the field of cell and gene therapy for cancer. Here are some highlights.
10 reasons to set up a recurring donation to Alliance for Cancer Gene Therapy
Your recurring gift can support cancer cell and gene therapy research year-round.
Leukemia survivor now 10 years cancer-free thanks to CAR T-cell therapy
This is the story of the night Austin Schuetz's mom learned her son was cancer-free.
ACGT Research Fellow makes progress in grant
Dr. Brian Brown is using ACGT funding to research and develop CARs that target macrophages aiding tumors.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
34.2
million dollars awarded to groundbreaking research.
63
research fellows awarded grants.
38
top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Juan Fueyo, MD
MD Anderson Cancer Center
ACGT is funding research that uses an oncolytic virus to fight glioblastoma, a deadly type of brain tumor.
Hideho Okada, MD, PhD
University of California San Francisco
ACGT is funding a new clinical trial for children with a rare brain cancer.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Juan Fueyo, MD
MD Anderson Cancer Center
ACGT is funding research that uses an oncolytic virus to fight glioblastoma, a deadly type of brain tumor.
Hideho Okada, MD, PhD
University of California San Francisco
ACGT is funding a new clinical trial for children with a rare brain cancer.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Stay up-to-date with us and get involved.
Oct 11, 2023
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today